A novel BCR-ABL fusion transcript (e15a2) in 2 patients with atypical chronic myeloproliferative syndrome

被引：0
|
作者：
Moreno, MD
Cortinas, MN
Bonomi, R
Cardeza, A
Uriarte, MD
机构：
来源：
BLOOD | 2001年 / 97卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3668 / 3669
页数：2
相关论文
共 50 条
  • [21] INDIVIDUAL EARLY DYNAMICS OF BCR-ABL TRANSCRIPTS, BUT NOT BCR-ABL TRANSCRIPT LEVELS AT BASELINE PREDICT SURVIVAL IN PATIENTS WITH CHRONIC PHASE CML
    Shlyakhto, V.
    Hanfstein, B.
    Lauseker, M.
    Erben, P.
    Saussele, S.
    Fabarius, A.
    Proetel, U.
    Schnittger, S.
    Kolb, H.
    Krause, S.
    Schubert, J.
    Einsele, H.
    Haenel, M.
    Dengler, J.
    Falge, C.
    Kanz, L.
    Neubauer, A.
    Kneba, M.
    Stegelmann, F.
    Pfreundschuh, M.
    Waller, C.
    Spiekermann, K.
    Baerlocher, G.
    Pfirrmann, M.
    Hasford, J.
    Hofmann, W.
    Hehlmann, R.
    Hochhaus, A.
    Mueller, M.
    HAEMATOLOGICA, 2013, 98 : 453 - 454
  • [22] E6a2 BCR-ABL fusion with BCR exon 5-deleted transcript in a Philadelphia positive CML responsive to Imatinib
    Popovici, C
    Cailleres, S
    David, M
    Lafage-Pochitaloff, M
    Sainty, D
    Mozziconacci, MJ
    LEUKEMIA & LYMPHOMA, 2005, 46 (09) : 1375 - 1377
  • [23] Chronic Myeloproliferative Neoplasm with Concurrent BCR-ABL Trans location and JAK2 Mutation
    Siddiqui, Nauman Saleem
    Ssiddiqui, Haroon Saleem
    Dr Qurat-ul-Ain
    Siddiqui, Saleem Ahmad
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2010, 20 (06): : 423 - 423
  • [24] CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WITH E14A2 BCR-ABL FUSION TRANSCRIPT ACHIEVE A FASTER MAJOR MOLECULAR REMISSION (MMR) ON IMATINIB THAN THOSE EXPRESSING THE E13A2 TRANSCRIPT
    Hanfstein, B.
    Erben, P.
    Agrawal, M.
    Schnittger, S.
    Schenk, T.
    Ernst, T.
    Hofmann, W. K.
    Hehlmann, R.
    Hochhaus, A.
    Mueller, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 337 - 337
  • [25] Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript
    A Tchirkov
    J-L Couderc
    B Périssel
    C Goumy
    A Regnier
    N Uhrhammer
    P Verrelle
    M Berger
    Leukemia, 2006, 20 : 167 - 168
  • [26] Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript
    Tchirkov, A
    Couderc, JL
    Périssel, B
    Goumy, C
    Regnier, A
    Uhrhammer, N
    Verrelle, P
    Berger, M
    LEUKEMIA, 2006, 20 (01) : 167 - 168
  • [27] Identification of novel BCR-ABL fusion transcript in two patients with persistent neutrophilia in absence of Philadelphia chromosome.
    Moreno, MP
    Cortinas, MN
    Bonomi, R
    Uriarte, MR
    BLOOD, 1999, 94 (10) : 177B - 177B
  • [28] A Novel e8a2BCR-ABL1 Fusion Transcript without Insertion Sequence in a Patient with Chronic Myeloid Leukemia
    Jin, Caibao
    Zhu, Xiaojian
    Xiao, Min
    Liu, Songya
    Liu, Xian
    Liu, Jingjing
    Xu, Xiuwen
    Yi, Shujuan
    Meng, Li
    ANNALS OF LABORATORY MEDICINE, 2018, 38 (02) : 169 - 171
  • [29] Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib.
    Cayuela, JM
    Rousselot, P
    Nicolini, F
    Espinouse, D
    Ollagnier, C
    Bui-Thi, MH
    Chabane, K
    Raffoux, E
    Tigaud, I
    Magaud, JP
    Hayette, S
    BLOOD, 2005, 106 (11) : 287B - 287B
  • [30] Consecutive but not isolated BCR-ABL transcript level rises are predictive of BCR-ABL kinase mutations in chronic myeloid leukaemia patients treated by imatinib
    Clark, RE
    Knight, K
    Lucas, CM
    Wang, L
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 52 - 52
12345